RISK WARNING: CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. Between 74% and 89% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
RISK WARNING: CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
Trusted Trading Platform
Free account
Worldwide Trading
Portfolio Management
novozymes

Novozymes

nasdaq copenhagen

Novonesis (Novozymes) - Class B (NSISBxcse) is a Danish biotechnology company headquartered in Bagsværd, near Copenhagen. Formed from the merger of Novozymes and Chr. Hansen, the company is the world's leading provider of biological solutions, including industrial enzymes, microorganisms, and bioinnovation products for the food, agriculture, household care, bioenergy, and pharmaceutical industries. Novonesis is a major constituent of the OMX Copenhagen 25 (C25) index on Nasdaq Copenhagen. The company is a global powerhouse in biosolutions and a key driver of the transition to more sustainable industrial processes.

 NSIS_B symbol info
 
 


 
Top stories by TradingView
 Technical analysis for NSIS_B
 
NSIS_B chart

Start trading
Novozymes now

At In2Markets, we offer unique strategies designed to align with your goals and adapt to changing market conditions. Our team will provide you with real-time support and expert insights to answer your question in a quick and personal way. Whether you’re trading or managing your portfolio, we combine innovation with a personalized approach to ensure you stay ahead.

Update I2M Telefoon (1)